BioCryst Pharmaceuticals, Inc. Total non-current assets

Total non-current assets of BCRX for past 10 years: annual, quarterly and twelve month trailing (TTM) including Total non-current assets growth rates and interactive chart. The sum of all non-current or long-term assets.


Highlights and Quick Summary

  • Total non-current assets for the quarter ending September 30, 2022 was $49.6 Million (a 216.18% increase compared to previous quarter)
  • Year-over-year quarterly Total non-current assets increased by 125.27%
  • Annual Total non-current assets for 2021 was $22 Million (a 101.69% increase from previous year)
  • Annual Total non-current assets for 2020 was $10.9 Million (a -0.2% decrease from previous year)
  • Annual Total non-current assets for 2019 was $10.9 Million (a -66.34% decrease from previous year)
Visit stockrow.com/BCRX for comprehensive keystats, realtime prices, income statement, balance sheet, cash flow statement with 10 years of data, and state-of-the-art screener.

Historical Total non-current assets of BioCryst Pharmaceuticals, Inc.

Most recent Total non-current assetsof BCRX including historical data for past 10 years.

Interactive Chart of Total non-current assets of BioCryst Pharmaceuticals, Inc.

BioCryst Pharmaceuticals, Inc. Total non-current assets for the past 10 Years (both Annual and Quarterly)

(All values are in $ million)

Year Q1 Q2 Q3 Q4 Fiscal Year
2022 $49.59 $15.69 $16.01
2021 $22.02 $13.02 $11.48 $10.66 $22.02
2020 $10.92 $13.79 $10.87 $11.08 $10.92
2019 $10.94 $11.7 $12.63 $24.69 $10.94
2018 $32.49 $39.81 $43.98 $51.22 $32.49
2017 $52.87 $16.12 $21.25 $16.01 $52.87
2016 $22.86 $26.87 $36.11 $52.46 $22.86
2015 $58.57 $54.45 $43.09 $48.5 $58.57
2014 $47.53 $1.98 $3.73 $7.66 $47.53
2013 $6.75 $6.37 $6.39 $11.49 $6.75
2012 $15.46 $17.51 $31.17 $27.14 $15.46

Business Profile of BioCryst Pharmaceuticals, Inc.

Sector: Healthcare
Industry: Biotechnology